Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses
DNA barcoding is a promising technology for the simultaneous analysis of genetic and phenotypic heterogeneity. Here, the authors combine DNA barcoding and single-cell RNA-seq to study heterogeneity, progression and response to therapy in B-cell acute lymphoblastic leukaemia patient-derived xenograft...
Enregistré dans:
Auteurs principaux: | Humberto Contreras-Trujillo, Jiya Eerdeng, Samir Akre, Du Jiang, Jorge Contreras, Basia Gala, Mary C. Vergel-Rodriguez, Yeachan Lee, Aparna Jorapur, Areen Andreasian, Lisa Harton, Charles S. Bramlett, Anna Nogalska, Gang Xiao, Jae-Woong Lee, Lai N. Chan, Markus Müschen, Akil A. Merchant, Rong Lu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1cf0a0d2c96e4d41be8c44bd2d61e2d2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Intratumoral heterogeneity and clonal evolution in liver cancer
par: Bojan Losic, et autres
Publié: (2020) -
Trial watch: intratumoral immunotherapy
par: Juliette Humeau, et autres
Publié: (2021) -
Clinical significance of intratumor heterogeneity for gynecological carcinoma
par: Ying-Chao Yang, et autres
Publié: (2015) -
Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
par: Sharanya Maanasi Kalasekar, et autres
Publié: (2021) -
Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
par: Andrea R. Di Sebastiano, et autres
Publié: (2018)